042520 — HANS BIOMED Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩320bn
- KR₩356bn
- KR₩90bn
Annual cashflow statement for HANS BIOMED, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22,126 | 4,923 | -24,092 | -7,800 | -32,075 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2,687 | -6,915 | 21,874 | 10,222 | 29,995 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -818 | -7,180 | -6,714 | -6,049 | -2,713 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -15,472 | -4,270 | -3,733 | 1,759 | 318 |
| Capital Expenditures | -5,208 | -4,134 | -2,067 | -2,829 | -1,758 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -15,983 | 7,301 | 5,387 | -3,766 | -3,480 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -21,190 | 3,167 | 3,320 | -6,595 | -5,237 |
| Financing Cash Flow Items | 1,204 | 864 | 1,053 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 29,738 | 1,387 | -829 | 5,865 | 5,810 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6,790 | 473 | -1,392 | 1,128 | 890 |